Cite
HARVARD Citation
Nichols, R. et al. (2019). Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies. Headache. 59 (2), pp. 192-204. [Online].